Underedited ribonucleic acid may sustain inflammation through an interferon feedback loop
In purified tissue cultures without immune cells, inadequately edited ribonucleic acid may sustain a self-reinforcing interferon response. Recurrence despite normalized editing, stopped only by correcting cell contact or the surrounding matrix, would reject the hypothesis.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 5 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Extracellular nucleic acid
Double-stranded RNA
RNA molecules with two paired strands that can be recognized by MDA5 and trigger an interferon response
Where this hypothesis actsIn tissue cells after prior stress, where inadequately edited transcripts persist after the initial stimulus is removed
Hypotheses on this target 1
Silencing1
Clearance restoration
Neutralisation
Accelerated excretion

What is proposed
Silencing
Selectively eliminate the causal double-stranded RNA transcripts
With whatNot stated in the record
HowBrief, targeted degradation of the implicated RNA transcripts
Possible result
Possible interruption of the self-sustaining interferon cycle and prevention of inflammatory relapse
From the recordКраткое адресное устранение причинных РНК или восстановление их редактирования должно разорвать цикл и стабилизировать SPV_6.

Enzyme
ADAR1
An enzyme that edits RNA, limiting recognition of endogenous RNA by MDA5
Where this hypothesis actsIn tissue cells with persistent, inadequately edited double-stranded RNA after prior stress
Hypotheses on this target 1
Inhibition
Activation
Lower level
Higher level
Replacement1
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation

What is proposed
Replacement
Restore catalytically active ADAR1 and its RNA-editing activity
With whatNot stated in the record
HowRestore catalytically active ADAR1, using a catalytically inactive variant as a comparison
Possible result
Possible prevention of inflammatory relapse that persists after the intervention is withdrawn
From the recordАдресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Inflammation may return after the conditions that first caused damage have been corrected. The unexpected move is to propose that tissue cells keep producing their own alarm signal: RNA, a molecule made from genetic instructions, that triggers inflammation and is then replenished by that response. This is a proposal generated by the pipeline, not a measured explanation of recurring inflammation or aging.
- Earlier stress is proposed to leave tissue cells persistently producing particular long double-stranded RNA molecules.
- Insufficient ADAR1 editing is proposed to leave those RNA molecules able to trigger immune recognition.
- MDA5 is proposed to detect that RNA and activate an interferon response.
- The interferon response is proposed to replenish the same triggering RNA, turning a response dependent on the original stress into a cycle that continues after the stress ends.
- Descendants of blood-forming cells are proposed to amplify the cycle, while tissue cells retain the ability to restart it without them.
- Brief removal of the responsible RNA or restoration of its editing is predicted to break the cycle and leave inflammation suppressed after the intervention ends.
Imagine a smoke alarm connected to a machine that makes smoke whenever the alarm sounds. The original smoke can clear while the alarm and machine keep one another going.
Where the picture breaks: The biological proposal requires the inflammatory response to replenish the same RNA that activates its detector. The picture assumes that connection exists and does not explain why a brief interruption would keep the biological cycle from restarting; both points require evidence.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.
Rests on: The goal is to generate ideas for extending life through a shared cause of several aging-related problems.
AssumptionThe goal takes as its starting possibility that mutually reinforcing aging processes contain a shared cause whose modification could benefit several systems. The supplied material does not establish such a target or a lifespan benefit.
- Goal pillarstep 02 of 04
Recovery should remain stable rather than allow a damaged condition to become entrenched.
Rests on: The search for a shared cause is narrowed to the persistence of damage after recovery.
AssumptionThe chain selects durable recovery as a route toward the master goal without establishing that the persistence of a damaged condition is a shared cause across aging systems.
- Gap questionstep 03 of 04
Returning inflammation could be sustained by a lasting program in tissue cells, in blood-forming precursor cells that produce later generations of blood cells, or by reinforcement between them. Separate and combined temporary suppression of these programs is proposed to distinguish those possibilities.
Rests on: The preceding stage identifies resistance to an entrenched damaged condition as the goal; this stage chooses recurring inflammation and lasting cellular programs as the concrete problem.
AssumptionThe narrowing assumes that inflammation returns after surrounding conditions normalize and that lasting programs in these cell populations are relevant candidate explanations. The preceding stage supplies no observations establishing either premise.
- Hypothesisstep 04 of 04
Previously stressed tissue cells are proposed to keep making long double-stranded RNA, whose two strands pair together, with insufficient editing by adenosine deaminase acting on RNA 1 (ADAR1), an enzyme that chemically changes RNA. Melanoma differentiation-associated protein 5 (MDA5), a cellular detector of double-stranded RNA, would recognize this material and trigger an interferon response, an immune signaling response associated with defense against viruses. The proposed new link is that this response promotes production of the same RNA, allowing inflammation to sustain itself after the original stress ends. Blood-cell descendants would amplify the response, but tissue alone could restart it; briefly removing the responsible RNA or restoring editing is predicted to produce lasting interruption.S2S5
Rests on: The previous stage explicitly allows tissue cells to carry a lasting inflammatory program. The supplied passage from Genome Biology (2026, S2) describes how ADAR1 editing prevents recognition of the cell’s own double-stranded RNA by MDA5, but does not establish persistent RNA production or recurring inflammation after stress. The supplied passage from Molecular Cell (2018, S5) likewise describes long paired RNA requiring ADAR1 editing to avoid MDA5 recognition, but does not establish the proposed self-sustaining cycle or a lasting treatment effect.
Supported by literature
What is carried, and what is not. The screened material speaks to two of the six mechanism links: RNA editing changing whether the cell’s own RNA is recognized, and RNA sensing activating an immune response. Those links have support in the supplied Genome Biology (2026, S2) passage, but that passage does not establish persistence after stress; no supplied source establishes the proposed sequence end to end or its durable interruption.S2
Where the reasoning is carried by something unstated · 3
- Master question. The goal takes as its starting possibility that mutually reinforcing aging processes contain a shared cause whose modification could benefit several systems. The supplied material does not establish such a target or a lifespan benefit.
- Goal pillar. The chain selects durable recovery as a route toward the master goal without establishing that the persistence of a damaged condition is a shared cause across aging systems.
- Gap question. The narrowing assumes that inflammation returns after surrounding conditions normalize and that lasting programs in these cell populations are relevant candidate explanations. The preceding stage supplies no observations establishing either premise.
How a result here could mislead · 3
- Inflammation in a culture cleared of immune cells could be read as proof that ordinary tissue cells restart it independently. The rival explanation involving fused tissue and immune cells could survive removal of recognizable immune cells. What closes it: The culture’s composition must be established, including whether cells formed by tissue–immune cell fusion remain. Attribution to ordinary tissue cells requires showing which cells produce the triggering RNA and restart inflammation.
- A fall in inflammation during RNA removal or restored editing could be mistaken for erasure of the lasting state. Continued treatment activity could suppress inflammation while the capacity to restart remains. What closes it: The proposed post-treatment observation must establish that the intervention has ceased acting, while following the specific RNA, its editing, MDA5 activation and returning inflammation. The observation period and recurrence criterion must be fixed in advance; neither is specified in the supplied design.
- More triggering RNA after interferon stimulation could be interpreted as increased production even if existing RNA simply lasts longer. That would not establish the proposed feedback link in which inflammation generates more of its own trigger. What closes it: The test must distinguish newly produced RNA from accumulated RNA and show that interferon stimulation increases production of the same specific molecules implicated before recurrence. Measurements of RNA amount alone cannot establish this link.
What would make this wrong. The proposal supplies a direct rejection condition: editing is restored, but inflammation still returns and is prevented only by correcting cell contact or the material surrounding cells. That result would contradict the claim that insufficiently edited RNA sustains recurrence in the tested system. The central feedback claim would also fail if interferon stimulation did not reproducibly restore production of the identified triggering RNA under the proposed test conditions.
What it would change. If the proposal held, lasting recovery in the tested tissue could depend on interrupting a self-sustaining RNA alarm rather than only correcting the conditions that first caused damage. Work pursuing a shared target for aging would then need to establish where this same cycle operates and whether its interruption benefits several systems. Even a successful tissue-culture test would leave effects across organs, aging in an intact organism and lifespan unestablished; the intended recovery measure called SPV_6 is not defined in the supplied material.
Sources read · 10
“Mechanistically, ADAR1 knockdown increased the association of endogenous dsRNA with melanoma differentiation-associated protein 5 (MDA5), restoring type I interferon (IFN) signaling.”
Does not settle: This source does not establish that interferon sustains production of the immunogenic transcripts through a positive feedback loop, that the cycle persists after an initial stressor is removed, or that it can restart in isolated non-malignant tissue.
A cytoplasmic index for quantifying immune-related A-to-I RNA editing. · Genome biology · 2026
“Editing by ADAR1 disrupts the base-pairing of the immunogenic self-dsRNAs to the extent that they are no longer recognized by MDA5, or marks them otherwise, preventing inappropriate activation of the antiviral cellular immune system [ – ].”
Does not settle: Источник оставляет открытыми существование положительной интерфероновой обратной связи, сохранение программы транскрипции после стресса, автономный повторный запуск в изолированной ткани, роль кроветворных потомков, эффект краткого устранения РНК или восстановления редактирования и стабилизацию SPV_6.
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway. · Cancer letters · 2025
“Our findings revealed that knockout Adar1 induces dsRNA accumulation, activating the TBK1-IRF3 pathway and stimulating interferon stimulating genes (ISGs) expression, which in turn activates anti-tumour immunity and suppresses lung cancer growth.”
Does not settle: Abstract reports ADAR1 loss in lung cancer cells. It does not establish a persistent interferon positive-feedback loop, prior stress, production of specific long dsRNA transcripts, autonomous reactivation in isolated tissue, hematopoietic contribution, or effects of transient RNA removal or restored editing on SPV_6.
Retinoic acid-inducible gene-I-like receptors. · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2011
“Because RLRs are IFN-inducible viral sensors, they are critical in amplifying antiviral responses.”
Does not settle: This abstract does not establish endogenous underedited RNA, ADAR1 involvement, MDA5 sensing of self RNA, persistence after stress, isolated-tissue re-initiation, or an interferon-driven loop producing immunogenic transcripts.
Cryo-EM Structures of MDA5-dsRNA Filaments at Different Stages of ATP Hydrolysis. · Molecular cell · 2018
“mRNA containing Alu repeats, endogenous retroelements of viral origin constituting 10% of the human genome, can hybridize into long RNA duplexes that must be deaminated by ADAR1 to avoid recognition by MDA5”
Does not settle: Источник описывает распознавание длинной двуцепочечной РНК MDA5 и необходимость редактирования ADAR1, но не устанавливает положительную обратную связь, при которой интерфероновый ответ поддерживает образование иммуногенных транскриптов, её сохранение после устранения стресса, повторный запуск в изолированной ткани, вклад кроветворных потомков или эффективность краткого устранения РНК либо восстановления редактирования.
Control of retrotransposon-driven activation of the interferon response by the double-stranded RNA binding protein DGCR8. · Nucleic acids research · 2026
“To this end, we generated DGCR8 knockout human cell lines and found that DGCR8 loss triggers a spontaneous type I IFN response. We show that the MDA5-MAVS pathway is responsible for the activation of the IFN response.”
Does not settle: This source text does not establish ADAR1-dependent underediting, persistence after a prior stress, an interferon-driven positive feedback loop sustaining immunogenic transcripts, tissue-autonomous recurrence, hematopoietic contributions, or whether RNA removal or restored editing stabilizes SPV_6.
Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression. · Current diabetes reports · 2015
“Melanoma differentiation-associated protein 5 (MDA5), encoded by IFIH1, mediates the innate immune system's interferon response to certain viral species that form double-stranded RNA (dsRNA), the MDA5 ligand, during their life cycle.”
Does not settle: This abstract does not establish ADAR1-dependent underediting of endogenous RNA, persistent immunogenic transcripts after stress, a self-sustaining interferon feedback loop, tissue-autonomous reactivation, hematopoietic contribution, or effects of removing causal RNAs or restoring editing.
Mutant TP53 hijacks RNA-splicing factor RBM28 to suppress double-stranded RNA triggered antitumor immunity. · Nature communications · 2026
“These TEs trigger innate immune sensing not only through the dsRNA they produce—which is recognized by intracellular sensors such as RIG-I-like receptors (RIG-I and MDA5) to initiate type I interferon (IFN) production —but also through other nucleic acid components.”
Does not settle: This source does not establish ADAR1 underediting, persistence after prior stress, an interferon-driven positive feedback loop producing immunogenic transcripts, autonomous restarting in isolated tissue, hematopoietic amplification, or effects of targeted RNA removal or restored editing.
Distinguishing self from non-self RNA by editing-specific inosine patterns. · 2026
“Endogenous dsRNAs are normally masked as “self” by A-to-I RNA editing through adenosine deaminases acting on RNA (ADARs), which prevents inadvertent activation of antiviral signaling [ – ].”
Does not settle: The source does not establish that interferon sustains production of the same immunogenic transcripts through a positive feedback loop after the initial stress is removed, that recurrence occurs in isolated tissue, the contribution of hematopoietic descendants, or that transient RNA removal or restored editing stabilizes SPV_6.
An Ultrastructural and Proteomic Analysis in DM1 Young Adults' Myoblasts: Stressed RER and Mitochondrial Dysfunction Involvement. · Journal of cellular and molecular medicine · 2026
“These transcripts may form stable, toxic base‐paired hairpin structures that translocate from the nucleus to the cytoplasm, forming dsRNAs that represent a danger signal within the cell.”
Does not settle: The source does not establish impaired ADAR1 editing, MDA5 sensing, an interferon-driven positive feedback loop that generates these transcripts, persistence after removal of an initial stressor, tissue-autonomous reactivation, or whether RNA removal/editing restoration stabilizes SPV_6.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?
Original wording · exactly as the pipeline generated it
Что возвращает воспаление после нормализации среды: автономная память тканевых клеток, память кроветворных предшественников или их взаимное подкрепление, выявляемое раздельным и совместным обратимым подавлением этих программ?
What this question is asking
The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the blood-forming precursor cells that produce immune cells, and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.
- Inflammation
- A response involving immune cells and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
- Cellular or inflammatory memory
- A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
- Tissue cells and autonomous tissue-cell memory
- Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
- Blood-forming stem and precursor cells
- Cells that give rise to blood cells, including immune cells. Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
- Immune cells
- Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
- Mechanical memory
- A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
- Metabolism and inherited metabolic memory
- Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
- Memory program and reversible suppression
- A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
- Mutual reinforcement
- A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
- Environmental correction
- Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
- Functional deficit
- A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
- Epithelial cells
- Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
- Cell-surface signaling protein
- A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
- Neutrophils
- A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
- Candida albicans
- The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.
Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including immune cells. The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.
The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in immune cells descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8
The same question asked without the part nothing read establishes:
- After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
- What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
- Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
- Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing immune cells with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered immune cells.
- Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
- Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the immune cells they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.
Механическая память RL-1 и наследуемая метаболическая память RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.
После устранения стимула траектории сходятся за недели; остаточный функциональный дефицит остаётся ниже заданных границ при повторных нагрузках месяцами.
Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Автономное возвращение воспаления возникает из-за нарушения распознавания собственной рибонуклеиновой кислоты (РНК). После прежнего стресса в тканевых клетках сохраняется программа образования длинных двуцепочечных транскриптов, которые недостаточно редактирует фермент ADAR1. Рецептор MDA5 воспринимает их как опасный материал и запускает интерфероновый ответ. Ключевое новое предположение состоит в положительной обратной связи: интерфероновый ответ поддерживает образование именно этих иммуногенных транскриптов, позволяя циклу пережить устранение первоначального стимула. Кроветворные потомки усиливают реакцию, но её повторный запуск возможен в изолированной ткани. Краткое адресное устранение причинных РНК или восстановление их редактирования должно разорвать цикл и стабилизировать SPV_6.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В очищенных тканевых культурах после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных двуцепочечных РНК и активация MDA5. Адресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а интерфероновая стимуляция должна воспроизводимо восстанавливать образование причинных транскриптов. Если редактирование нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или матрикса, гипотеза отвергается.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable intervention outcomes, persistence after withdrawal, reproducible restoration, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны определение участков редактирования РНК, выделение двуцепочечных транскриптов, подавление отдельных РНК и сравнение активного и неактивного фермента. Исследование ADAR1 показало, что потеря его редактирующей активности вызывает распознавание эндогенной РНК через MDA5. [Liddicoat et al., Science, 2015](https://pubmed.ncbi.nlm.nih.gov/26275108/). Долговременная положительная обратная связь при старении требует самостоятельного доказательства.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В очищенных тканевых культурах после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных двуцепочечных РНК и активация MDA5. Адресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а интерфероновая стимуляция должна воспроизводимо восстанавливать образование причинных транскриптов. Если редактирование нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или матрикса, гипотеза отвергается.
- Rival 01 of 03What would separate them
Cell fusion may restart inflammation by combining tissue and immune programs in persistent hybrids predicts: После раздельного и совместного обратимого подавления тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены геномы обеих линий. Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних негибридных клеток этого эффекта не даёт. Обнаружение устойчивого рецидива в культурах с надёжно исключённым слиянием и его устранение коррекцией геометрии контакта, редактирования РНК или матриксных пептидов опровергает гипотезу как основное объяснение.
- Rival 02 of 03What would separate them
Wider cell contacts may prevent enzyme exclusion, impair clearance and renew inflammation predicts: При одинаковых плотности лиганда, сродстве рецептора, составе клеток и текущей среде изменение только длины инертного молекулярного соединителя меняет присутствие CD45 в контакте, фосфорилирование рецептора и вероятность завершённого поглощения. Короткий контакт восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних ядерных программ. Укорочение внеклеточной части CD45 должно отменять этот эффект, поскольку укороченная фосфатаза снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.
- Rival 03 of 03Matrix breakdown may restart inflammation through a peptide-driven feedback loop
Not yet published.
What would separate themMatrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: Бесклеточная пептидная фракция ранее повреждённой ткани запускает привлечение нейтрофилов в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления PGP и возвращается при добавлении синтетического пептида в измеренной исходной концентрации. Замена клеток при сохранённом матриксе допускает рецидив; химическая обработка матрикса при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных пептидов, особенно при зависимости от MDA5 или геометрии фагоцитарного контакта, опровергает гипотезу.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
1 of 1 cited studies could be located, and 0 of 0 figures are not carried by one that resolved.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
1 citation handle extracted; 2 Europe PMC searches run; 3 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.